Management of venous leg ulcers with a lipidocolloid matrix impregnated with NOSF (Nano-Oligosaccharide Factor)
Author(s) : P. Leger, F. Vin, H. Paradis, J.-P. Gobin, O. Tacca, S. Bohbot and al.
The Nano-Oligosaccharide Factor (NOSF) is a new compound aiming to promote wound closure mainly through inhibition of Matrix Metalloproteinases (MMPs) present in excess in chronic wounds. This factor is incorporated within a lipido-colloid matrix (TLC-NOSF matrix) and locally released in the wound.